Induction of Tumors in Mice by Genomic Hypomethylation
The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
Genome-wide DNA hypomethylation occurs in many human cancers, but whether this epigenetic change is a cause or consequence of tumorigenesis has been unclear. To explore this phenomenon, we generated mice carrying a hypomorphic DNA methyltransferase 1 ( Dnmt1 ) allele, which reduces Dnmt1 expression to 10% of wild-type levels and results in substantial genome-wide hypomethylation in all tissues. The mutant mice were runted at birth, and at 4 to 8 months of age they developed aggressive T cell lymphomas that displayed a high frequency of chromosome 15 trisomy. These results indicate that DNA hypomethylation plays a causal role in tumor formation, possibly by promoting chromosomal instability.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Reduced DNA methylation (hypomethylation) in mice increases the risk of aneuploidy and cancer (Gaudet et al., 2003)”
From The Aging Epigenome (2016) · cites this paper as Gaudet et al., 2003
In the citing paper
“Indeed, the global DNA hypomethylation, especially occurring on intragenic regions, is a general feature of most tumours [35][36][37] .”
From Intragenic DNA methylation prevents spurious transcription initiation (2017) · cites this paper as [36]
Citations
Cites
Jaenisch, R., & Bird, A. (2003) · Nature Genetics · doi:10.1038/ng1089 · Cited by 6,325
Self-citationThe fundamental role of epigenetic events in cancer
Jones, P. A., & Baylin, S. B. (2002) · Nature Reviews Genetics · doi:10.1038/nrg816 · Cited by 5,648
Targeted mutation of the DNA methyltransferase gene results in embryonic lethality
Li, E., Bestor, T. H., & Jaenisch, R. (1992) · Cell · doi:10.1016/0092-8674(92)90611-f · Cited by 3,984
Self-citationHypomethylation distinguishes genes of some human cancers from their normal counterparts
Feinberg, A. P., & Vogelstein, B. (1983) · Nature · doi:10.1038/301089a0 · Cited by 2,437
Loss of the Suv39h Histone Methyltransferases Impairs Mammalian Heterochromatin and Genome Stability
Peters, A. H. F. M., O'Carroll, D., Scherthan, H., Mechtler, K., Sauer, S., Schöfer, C., Weipoltshammer, K., Pagani, M., Lachner, M., Kohlmaier, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00542-6 · Cited by 1,766
DNA methylation in cancer: too much, but also too little
Ehrlich, M. (2002) · Oncogene · doi:10.1038/sj.onc.1205651 · Cited by 1,538
Chromosomal Instability and Tumors Promoted by DNA Hypomethylation
Eden, A., Gaudet, F., Waghmare, A., & Jaenisch, R. (2003) · Science · doi:10.1126/science.1083557 · Cited by 1,399
Self-citationXu, G.-L., Bestor, T. H., Bourc'his, D., Hsieh, C.-L., Tommerup, N., Bugge, M., Hulten, M., Qu, X., Russo, J. J., & Viegas-Péquignot, E. (1999) · Nature · doi:10.1038/46052 · Cited by 1,203
Transcription of IAP endogenous retroviruses is constrained by cytosine methylation
Walsh, C. P., Chaillet, J. R., & Bestor, T. H. (1998) · Nature Genetics · doi:10.1038/2413 · Cited by 1,105
DNA hypomethylation leads to elevated mutation rates
Chen, R. Z., Pettersson, U., Beard, C., Jackson-Grusby, L., & Jaenisch, R. (1998) · Nature · doi:10.1038/25779 · Cited by 954
Self-citation
Research works printed but not linked: 3
- S. Cory, D. L. Vaux, A. Strasser, A. W. Harris, J. M. Adams, Cancer Res.59 (suppl.), 1685s (1999).
- E. Wainfan, L. A. Poirier, Cancer Res.52, 2071s (1992).
- V. Zagonelet al., Leukemia7 (suppl. 1), 30 (1993).
Cited by
Esteller, M. (2008) · New England Journal of Medicine · doi:10.1056/nejmra072067 · Cited by 3,662
Gene Silencing in Cancer in Association with Promoter Hypermethylation
Herman, J. G., & Baylin, S. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmra023075 · Cited by 3,422
Epigenetic modifications and human disease
Portela, A., & Esteller, M. (2010) · Nature Biotechnology · doi:10.1038/nbt.1685 · Cited by 2,836
“Global hypomethylation occurs mainly at repetitive sequences, promoting chromosomal instability, translocations, gene disruption and reactivation of endoparasitic sequence”
BackgroundThe history of cancer epigenetics
Feinberg, A. P., & Tycko, B. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1279 · Cited by 2,344
“These results indicate that hypomethylation might abate the risk of cancer, but more recent studies from Jaenisch and colleagues indicate just the opposite, with a high frequency of lymphomas in mice with a hypomorphic Dnmt1 allel”
ResultCancer epigenomics: DNA methylomes and histone-modification maps
Esteller, M. (2007) · Nature Reviews Genetics · doi:10.1038/nrg2005 · Cited by 2,146
“The maintenance of this DNA methylation could have a role in the protection of chromosomal integrity, by preventing chromosomal instability, translocations and gene disruption through the reactivation of endoparasitic sequences”
BackgroundEUKARYOTIC CYTOSINE METHYLTRANSFERASES
Goll, M. G., & Bestor, T. H. (2005) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.74.010904.153721 · Cited by 2,063
The epigenetic progenitor origin of human cancer
Feinberg, A. P., Ohlsson, R., & Henikoff, S. (2006) · Nature Reviews Genetics · doi:10.1038/nrg1748 · Cited by 1,853
Weber, M., Davies, J. J., Wittig, D., Oakeley, E. J., Haase, M., Lam, W. L., & Schübeler, D. (2005) · Nature Genetics · doi:10.1038/ng1598 · Cited by 1,754
“Further genomic and epigenomic analysis, similar to that reported here, of multiple tumor samples will be required to elucidate whether these extended regions are frequent targets and whether they coincide with sites of genomic instability, as has been suggested on the basis of analysis of knockouts of genes encoding…”
BackgroundMaherali, N., Sridharan, R., Xie, W., Utikal, J., Eminli, S., Arnold, K., Stadtfeld, M., Yachechko, R., Tchieu, J., Jaenisch, R., et al. (2007) · Cell stem cell · doi:10.1016/j.stem.2007.05.014 · Cited by 1,725
“Thus, the question of epigenetic reprogramming is of particular relevance for the potential therapeutic applications of iPS cells, as epigenetic aberrations can result in pathological conditions such as cancer ( Gaudet et al., 2003 ).”
BackgroundSelf-citationPhenotypic plasticity and the epigenetics of human disease
Feinberg, A. P. (2007) · Nature · doi:10.1038/nature05919 · Cited by 1,613
“Hypomethylation also causes increased chromosomal instability, leading to aggressive T-cell lymphoma”
BackgroundDas, P. M., & Singal, R. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.07.151 · Cited by 1,456
“mice developed aggressive T-cell lymphomas that displayed a high frequency of chromosome 15 trisomy.(22) Therefore,”
BackgroundEpigenetic Determinants of Cancer
Baylin, S. B., & Jones, P. A. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a019505 · Cited by 1,226
“Indeed, deletion or reduction of the maintenance DNA methyltransferase, Dnmt1, results in increased mutation rates, aneuploidies, and tumor induction, a clear indication that DNA hypomethylation plays an active role in increasing chromosomal fragility (Chen et al. 1998; Narayan et al. 1998; Gaudet et al. 2003; Ehrlich…”
BackgroundEpigenetic therapy of cancer: past, present and future
Yoo, C. B., & Jones, P. A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1930 · Cited by 1,289
“The use of demethylating agents can aggravate the situation by further decreasing the level of methylation and activation of genes that are potentially deleterious — that is, oncogene”
BackgroundImpaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2
Ko, M., Huang, Y., Jankowska, A. M., Pape, U. J., Tahiliani, M., Bandukwala, H. S., An, J., Lamperti, E. D., Koh, K. P., Ganetzky, R., et al. (2010) · Nature · doi:10.1038/nature09586 · Cited by 1,213
Reduced representation bisulfite sequencing for comparative high-resolution DNA methylation analysis
Meissner, A. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki901 · Cited by 1,217
The epigenetics of epithelial-mesenchymal plasticity in cancer
Tam, W. L., & Weinberg, R. A. (2013) · Nature Medicine · doi:10.1038/nm.3336 · Cited by 1,163
Dna Hypomethylation In Cancer Cells
Ehrlich, M. (2009) · Epigenomics · doi:10.2217/epi.09.33 · Cited by 1,060
Fang, M., Wang, Y., Ai, N., Hou, Z., Sun, Y., Lu, H., Welsh, W. J., & Yang, C. S. (2003) · PubMed · Cited by 1,201
DNA methylation aging clocks: challenges and recommendations
Bell, C. G., Lowe, R., Adams, P. D., Baccarelli, A. A., Beck, S., Bell, J. T., Christensen, B. C., Gladyshev, V. N., Heijmans, B. T., Horvath, S., et al. (2019) · Genome Biology · doi:10.1186/s13059-019-1824-y · Cited by 1,025
“Repetitive regions possess latent functionality [152, 153], however are robustly epigenetically repressed by DNA methylation [151, 154, 155].”
Li, E., & Zhang, Y. (2014) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a019133 · Cited by 946
Modes of action of the DNA methyltransferase inhibitors azacytidine and decitabine
Stresemann, C., & Lyko, F. (2008) · International Journal of Cancer · doi:10.1002/ijc.23607 · Cited by 949
“Mouse models with strongly and permanently reduced DNA methylation levels have shown genetic amplification and insertional activation of oncogenic loci.(30,31) These events are probably linked to the epigenetic reactivation of mobile DNA elements and need to be monitored and minimized during demethylation therapy.”
BackgroundEpigenetic Alterations in Colorectal Cancer: Emerging Biomarkers
Okugawa, Y., Grady, W. M., & Goel, A. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.07.011 · Cited by 782
Intragenic DNA methylation prevents spurious transcription initiation
Neri, F., Rapelli, S., Krepelova, A., Incarnato, D., Parlato, C., Basile, G., Maldotti, M., Anselmi, F., & Oliviero, S. (2017) · Nature · doi:10.1038/nature21373 · Cited by 739
Cortellino, S., Xu, J., Sannai, M., Moore, R., Caretti, E., Cigliano, A., Le Coz, M., Devarajan, K., Wessels, A., Soprano, D., et al. (2011) · Cell · doi:10.1016/j.cell.2011.06.020 · Cited by 809
DNA hypomethylation and human diseases
Wilson, A. S., Power, B. E., & Molloy, P. L. (2007) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2006.08.007 · Cited by 804
“Some of these events have been observed in vitro and using in vivo animal models [20,27–30], but their relative importance in human disease is not understood.”
BackgroundMetabolic reprogramming and epigenetic modifications on the path to cancer
Sun, L., Zhang, H., & Gao, P. (2022) · Protein & Cell · doi:10.1007/s13238-021-00846-7 · Cited by 770
“In mice, DNA hypomethylation is sufficient to induce aggressive T-cell lymphomas with a high frequency of chromosome 15 trisomy (Eden et al., 2003; Gaudet et al., 2003), whereas tumor suppressor genes are usually silenced by site-specific DNA hypermethylation at their promoters (Esteller et al.”
BackgroundTumorigenicity as a clinical hurdle for pluripotent stem cell therapies
Lee, A. S., Tang, C., Rao, M. S., Weissman, I. L., & Wu, J. C. (2013) · Nature Medicine · doi:10.1038/nm.3267 · Cited by 727
Intra-individual Change Over Time in DNA Methylation With Familial Clustering
Bjornsson, H. T. (2008) · JAMA · doi:10.1001/jama.299.24.2877 · Cited by 702
“Similarly, animal studies have shown that a loss of DNA methylation increases intestinal adenoma initiation and a gain of DNA methylation increases adenoma progression.(29) Similarly, both hypomethylation and hypermethylation could lead to autoimmune disease by activating autoreactivity genes or silencing histocompati…”
Structure and Function of Mammalian DNA Methyltransferases
Jurkowska, R. Z., Jurkowski, T. P., & Jeltsch, A. (2011) · ChemBioChem · doi:10.1002/cbic.201000195 · Cited by 690
Ko, M., Bandukwala, H. S., An, J., Lamperti, E. D., Thompson, E. C., Hastie, R., Tsangaratou, A., Rajewsky, K., Koralov, S. B., & Rao, A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1112317108 · Cited by 616
“In the hematopoietic system, whole-genome sequencing and other genetic analyses have identified recurrent somatic alterations that contribute to the pathogenesis of a variety of myeloidmalignancies (1, 2);many of thesemutations involve proteins that regulate the epigenetic landscape of cancer cells by altering DNA met…”
BackgroundChromatin replication and epigenome maintenance
Alabert, C., & Groth, A. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3288 · Cited by 592
Chemoprevention of colon cancer by calcium, vitamin D and folate: molecular mechanisms
Lamprecht, S. A., & Lipkin, M. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1144 · Cited by 583
“Genomic hypomethylation in these mice leads to tumour formation and to marked chromosome instabilit”
BackgroundFazio, V., Robertis, M., Massi, E., Poeta, M., Carotti, S., Morini, S., Cecchetelli, L., & Signori, E. (2011) · Journal of Carcinogenesis · doi:10.4103/1477-3163.78279 · Cited by 579
“It has indeed been shown in both the AOM-induced and mutant Apc mouse models of intestinal cancer that the global DNA hypomethylation observed in human colorectal malignancy[122] is also present in tumors arising in these mice.[60,123]”
BackgroundTesting gene function early in the B cell lineage in mb1-cre mice
Hobeika, E., Thiemann, S., Storch, B., Jumaa, H., Nielsen, P. J., Pelanda, R., & Reth, M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605944103 · Cited by 579
Regulation and function of DNA methylation in plants and animals
He, X.-J., Chen, T., & Zhu, J.-K. (2011) · Cell Research · doi:10.1038/cr.2011.23 · Cited by 555
ABERRANT DNA METHYLATION AS A CANCER-INDUCING MECHANISM
Esteller, M. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095832 · Cited by 549
“Is it really a “causative” factor? Or just a “modulator of cancer risk?” Or only a “bystander passenger?” The studies in mouse models are extremely interesting but puzzling: When the mouse deficient in DNA methylation owing to a defect in DNMT1 is crossed with the colon adenomaprone Min mouse (with a genetic defect in…”
BackgroundBrueckner, B., Garcia Boy, R., Siedlecki, P., Musch, T., Kliem, H. C., Zielenkiewicz, P., Suhai, S., Wiessler, M., & Lyko, F. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2957 · Cited by 545
“This might provide a considerable advantage for the maintenance of chromosome stability in demethylated cells, which has been shown to be affected by the hypomethylation of satellite DNA (4, 5).”
BackgroundTsumura, A., Hayakawa, T., Kumaki, Y., Takebayashi, S., Sakaue, M., Matsuoka, C., Shimotohno, K., Ishikawa, F., Li, E., Ueda, H. R., et al. (2006) · Genes to Cells · doi:10.1111/j.1365-2443.2006.00984.x · Cited by 542
“Reduction of Dnmt1 activity in mice has been shown to induce tumors and chromosomal instability (Eden et al. 2003; Gaudet et al. 2003), and global hypomethylation in male germ cells results in meiotic abnormality (Bourc’his & Bestor 2004; Hata et al. 2006).”
BackgroundDNA methylation dynamics in health and disease
Bergman, Y., & Cedar, H. (2013) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2518 · Cited by 592
The Colorful History of Active DNA Demethylation
Ooi, S. K. T., & Bestor, T. H. (2008) · Cell · doi:10.1016/j.cell.2008.06.009 · Cited by 537
“This implies that methylation patterns are not significantly affected by the loss of these glycosylases, even though it has been shown that small increases or decreases in genomic m5C cause severe abnormalities or death in mutant mice (Gaudet et al., 2003).”
BackgroundDNA methylation loss promotes immune evasion of tumours with high mutation and copy number load
Jung, H., Kim, H. S., Kim, J. Y., Sun, J.-M., Ahn, J. S., Ahn, M.-J., Park, K., Esteller, M., Lee, S.-H., & Choi, J. K. (2019) · Nature Communications · doi:10.1038/s41467-019-12159-9 · Cited by 529
Recurrent DNMT3A mutations in patients with myelodysplastic syndromes
Walter, M. J., Ding, L., Shen, D., Shao, J., Grillot, M., McLellan, M., Fulton, R., Schmidt, H., Kalicki-Veizer, J., O'Laughlin, M., et al. (2011) · Leukemia · doi:10.1038/leu.2011.44 · Cited by 527
Booth, L. N., & Brunet, A. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.05.013 · Cited by 499
“Reduced DNA methylation (hypomethylation) in mice increases the risk of aneuploidy and cancer (Gaudet et al., 2003), suggesting that the observed age-associated DNA hypomethylation could contribute to chromosome instability with age.”
BackgroundDNA Methyltransferase Inhibitors and the Development of Epigenetic Cancer Therapies
Lyko, F., & Brown, R. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji311 · Cited by 510
Regulation of transposable elements by DNA modifications
Deniz, Ö., Frost, J. M., & Branco, M. R. (2019) · Nature Reviews Genetics · doi:10.1038/s41576-019-0106-6 · Cited by 486
Lund, A. H., & van Lohuizen, M. (2004) · Genes & Development · doi:10.1101/gad.1232504 · Cited by 489
“…stem cells deficient for the Dnmt1 maintenance methyltransferase display an increased frequency of chromosomal rearrangements (Chen et al. 1998), and mice carrying a hypomorph Dnmt1 allele develop aggressive lymphomas displaying a high frequency of genomic rearrangements (Gaudet et al. 2003).”
BackgroundGuidelines and Techniques for the Generation of Induced Pluripotent Stem Cells
Maherali, N., & Hochedlinger, K. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.11.008 · Cited by 486
“For instance, 5-azacytidine is mutagenic (JacksonGrusby et al., 1997), and mice with global alterations in DNA methylation levels develop tumors at a high frequency (Gaudet et al., 2003).”
BackgroundDNA methylation and DNA methyltransferases
Edwards, J. R., Yarychkivska, O., Boulard, M., & Bestor, T. H. (2017) · Epigenetics & Chromatin · doi:10.1186/s13072-017-0130-8 · Cited by 484
“That mutations in DNMT1 should cause adult-onset neurological defects without involvement of other tissues is unexpected; partial loss-of-function alleles of Dnmt1 in mice cause pervasive developmental delays and high rates of leukemia without obvious neurological abnormalities [49].”
BackgroundDetection and interpretation of altered methylation patterns in cancer cells
Ushijima, T. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1571 · Cited by 483
“Altered methylation levels, especially hypomethylation, can cause genomic instability and, consequently, tumour formatio”
BackgroundEnvironmental chemical exposures and human epigenetics
Hou, L., Zhang, X., Wang, D., & Baccarelli, A. (2012) · International Journal of Epidemiology · doi:10.1093/ije/dyr154 · Cited by 483
DNA methylation protects hematopoietic stem cell multipotency from myeloerythroid restriction
Bröske, A.-M., Vockentanz, L., Kharazi, S., Huska, M. R., Mancini, E., Scheller, M., Kuhl, C., Enns, A., Prinz, M., Jaenisch, R., et al. (2009) · Nature Genetics · doi:10.1038/ng.463 · Cited by 478
“DNA methylation maintains homeostasis within the HSC pool Given the short life span and complete HSC loss in Dnmt1 Δ/Δ mice, we next combined a hypomorphic Dnmt1 allele ( Dnmt1 chip ) with a null allel”
BackgroundSelf-citationEpigenetics and human disease: translating basic biology into clinical applications
Rodenhiser, D. (2006) · Canadian Medical Association Journal · doi:10.1503/cmaj.050774 · Cited by 473
DNA Methylation Cancer Biomarkers: Translation to the Clinic
Locke, W. J., Guanzon, D., Ma, C., Liew, Y. J., Duesing, K. R., Fung, K. Y. C., & Ross, J. P. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.01150 · Cited by 472
Lei, Z., Tan, I. B., Das, K., Deng, N., Zouridis, H., Pattison, S., Chua, C., Feng, Z., Guan, Y. K., Ooi, C. H., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.05.010 · Cited by 458
Plass, C., Pfister, S. M., Lindroth, A. M., Bogatyrova, O., Claus, R., & Lichter, P. (2013) · Nature Reviews Genetics · doi:10.1038/nrg3554 · Cited by 453
Folate and colorectal cancer: An evidence‐based critical review
Kim, Y. (2007) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200600191 · Cited by 419
Chalitchagorn, K., Shuangshoti, S., Hourpai, N., Kongruttanachok, N., Tangkijvanich, P., Thong-ngam, D., Voravud, N., Sriuranpong, V., & Mutirangura, A. (2004) · Oncogene · doi:10.1038/sj.onc.1208137 · Cited by 417
“Global losses of methylation in cancer may lead to alterations in the expression of proto-oncogenes critical to carcinogenesis and may facilitate chromosomal instability (Dunn, 2003; Gaudet et al., 2003).”
BackgroundFang, M. Z., Chen, D., Sun, Y., Jin, Z., Christman, J. K., & Yang, C. S. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0406 · Cited by 410
Laird, P. W. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi113 · Cited by 398
“Increased lymphomagenesis in Dnmt1 hypomorphic mice was subsequently confirmed in mice without an Mlh1 mutation (178).”
BackgroundChromatin dynamics during cellular reprogramming
Apostolou, E., & Hochedlinger, K. (2013) · Nature · doi:10.1038/nature12749 · Cited by 398
Epigenetic regulation in the tumor microenvironment: molecular mechanisms and therapeutic targets
Yang, J., Xu, J., Wang, W., Zhang, B., Yu, X., & Shi, S. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01480-x · Cited by 388
Calvisi, D. F., Ladu, S., Gorden, A., Farina, M., Lee, J.-S., Conner, E. A., Schroeder, I., Factor, V. M., & Thorgeirsson, S. S. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31457 · Cited by 393
Histone H3-K9 Methyltransferase ESET Is Essential for Early Development
Dodge, J. E., Kang, Y.-K., Beppu, H., Lei, H., & Li, E. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.6.2478-2486.2004 · Cited by 391
“Epigenetic modifications of heterochromatin appear to play important roles in maintaining chromosomal stability, which if deregulated can result in cancer (5).”
BackgroundLarge-scale structure of genomic methylation patterns
Rollins, R. A., Haghighi, F., Edwards, J. R., Das, R., Zhang, M. Q., Ju, J., & Bestor, T. H. (2006) · Genome Research · doi:10.1101/gr.4362006 · Cited by 389
“2002), while partial demethylation of the genome in mice that carry hypomorphic alleles of Dnmt1 leads to high rates of lymphoma (Gaudet et al. 2002).”
BackgroundEpigenetics in metal carcinogenesis: nickel, arsenic, chromium and cadmium
Arita, A., & Costa, M. (2009) · Metallomics · doi:10.1039/b903049b · Cited by 387
DNA methyltransferases and their roles in tumorigenesis
Zhang, W., & Xu, J. (2017) · Biomarker Research · doi:10.1186/s40364-017-0081-z · Cited by 382
“have demonstrated that deletion or reduction of DNMT1 leads to substantial genome-wide hypomethylation and chromosomal instability [51].”
BackgroundRecruitment of DNA methyltransferase I to DNA repair sites
Mortusewicz, O., Schermelleh, L., Walter, J., Cardoso, M. C., & Leonhardt, H. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501034102 · Cited by 380
Self-citationLim, S.-O., Gu, J.-M., Kim, M. S., Kim, H.-S., Park, Y. N., Park, C. K., Cho, J. W., Park, Y. M., & Jung, G. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.07.027 · Cited by 381
A Cohort Study of Tumoral LINE-1 Hypomethylation and Prognosis in Colon Cancer
Ogino, S., Nosho, K., Kirkner, G. J., Kawasaki, T., Chan, A. T., Schernhammer, E. S., Giovannucci, E. L., & Fuchs, C. S. (2008) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djn359 · Cited by 377
Epigenetics, DNA Methylation, and Chromatin Modifying Drugs
Szyf, M. (2009) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-061008-103102 · Cited by 374
“Although knockout of dnmt1 protected mice from colorectal cancer, dnmt1 hypomorph alleles promoted thymic lymphomas in mice (136).”
BackgroundDNA methylation profiles in cancer diagnosis and therapeutics
Pan, Y., Liu, G., Zhou, F., Su, B., & Li, Y. (2018) · Clinical and Experimental Medicine · doi:10.1007/s10238-017-0467-0 · Cited by 373
The Biology of Aging and Cancer: A Brief Overview of Shared and Divergent Molecular Hallmarks
Aunan, J. R., Cho, W. C., & Søreide, K. (2017) · Aging and disease · doi:10.14336/ad.2017.0103 · Cited by 373
“Cancer is also associated with hypomethylation and activation of protooncogenes and this seems to have a causative role in oncogenesis by causing chromosomal instability [56].”
BackgroundEpigenetic regulation of gene expression in physiological and pathological brain processes
Gräff, J., Kim, D., Dobbin, M. M., & Tsai, L.-H. (2011) · Physiological Reviews · doi:10.1152/physrev.00012.2010 · Cited by 373
“While the implications of this epigenetic alteration are poorly understood, it has been shown that global hypomethylation triggers genomic instability and is sufficient to lead to tumorigenesis (106).”
BackgroundReprogramming of a melanoma genome by nuclear transplantation
Hochedlinger, K., Blelloch, R., Brennan, C., Yamada, Y., Kim, M., Chin, L., & Jaenisch, R. (2004) · Genes & Development · doi:10.1101/gad.1213504 · Cited by 367
“2000), a hypomethylated Chip/c lymphoma (Gaudet et al. 2003), a p53 breast cancer cell line (Kuperwasser et al.”
BackgroundSelf-citationPan-Cancer Landscape of Aberrant DNA Methylation across Human Tumors
Saghafinia, S., Mina, M., Riggi, N., Hanahan, D., & Ciriello, G. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.09.082 · Cited by 357
“…a recently proposed stemness signature based on hypo-methylation of specific loci (Malta et al., 2018) and with the extent of chromosomal alterations in lung, prostate, stomach, and uterine carcinoma, supporting a link between DNA hypo-methylation and chromosomal instability (Gaudet et al., 2003).”
Senescent cells harbour features of the cancer epigenome
Cruickshanks, H. A., McBryan, T., Nelson, D. M., VanderKraats, N. D., Shah, P. P., van Tuyn, J., Singh Rai, T., Brock, C., Donahue, G., Dunican, D. S., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2879 · Cited by 358
Driver and Passenger Mutations in Cancer
Pon, J. R., & Marra, M. A. (2015) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012414-040312 · Cited by 355
Epigenomics: beyond CpG islands
Fazzari, M. J., & Greally, J. M. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1349 · Cited by 352
“, which has been observed in mice with hypomethylated genomes due to engineered methyltransferase deficiencie”
BackgroundHoward, G., Eiges, R., Gaudet, F., Jaenisch, R., & Eden, A. (2008) · Oncogene · doi:10.1038/sj.onc.1210631 · Cited by 343
“To understand the effects of genomewide hypomethylation and the significance of this change in cancer, we developed a hypomorphic allele for the maintenance of DNA methyltransferase (Dnmt1Chip) (Gaudet et al., 2003).”
BackgroundInfluentialSelf-citationRodriguez, J., Frigola, J., Vendrell, E., Risques, R.-A., Fraga, M. F., Morales, C., Moreno, V., Esteller, M., Capellà, G., Ribas, M., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0293 · Cited by 335
“8), and an increased mutation rate owing to DNMT1 deficiency in murine embryonic stem cells (9) and in murine somatic cells (10, 11).”
BackgroundThe epigenetics of cancer etiology
Feinberg, A. P. (2004) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2004.06.005 · Cited by 337
Epigenetic modulation of antitumor immunity for improved cancer immunotherapy
Dai, E., Zhu, Z., Wahed, S., Qu, Z., Storkus, W. J., & Guo, Z. S. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01464-x · Cited by 328
“tumor suppressor gene pathways in a broad range of tissue histologies [5, 6], as well as by impacting the activation, differentiation, and functional fate of immune cells such as T cells and NK cells that serve as a surveillance mechanism against cancer [4, 7–10].”
BackgroundEpigenetic factors in aging and longevity
Gravina, S., & Vijg, J. (2010) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-009-0730-7 · Cited by 329
“lation initiates chromosome instability and increased tumor frequency, as has been shown in mouse models [26, 36, 91].”
BackgroundGuo, S.-W. (2009) · Molecular Human Reproduction · doi:10.1093/molehr/gap064 · Cited by 328
“Since global hypomethylation is a notable feature of cancer and is reported to cause genomic instability (Eden et al., 2003; Gaudet et al., 2003), there may be a legitimate concern as whether the use of DMAs and/or HDACIs in treating endometriosis would increase the risk for cancer.”
BackgroundMolecular and Cellular Heterogeneity in Breast Cancer
Rivenbark, A. G., O’Connor, S. M., & Coleman, W. B. (2013) · The American Journal of Pathology · doi:10.1016/j.ajpath.2013.08.002 · Cited by 327
Defining Driver DNA Methylation Changes in Human Cancer
Pfeifer, G. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19041166 · Cited by 323
“Earlier studies with hypomorphic mouse mutants of Dnmt genes have suggested that methylation loss is potentially causative for cancer formation [28,29].”
BackgroundStructure and Function of Eukaryotic DNA Methyltransferases
Chen, T., & Li, E. (2004) · Current Topics in Developmental Biology · doi:10.1016/s0070-2153(04)60003-2 · Cited by 321
High-resolution mapping of DNA hypermethylation and hypomethylation in lung cancer
Rauch, T. A., Zhong, X., Wu, X., Wang, M., Kernstine, K. H., Wang, Z., Riggs, A. D., & Pfeifer, G. P. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710735105 · Cited by 318
“DNA hypomethylation in cancer tissue was first observed more than two decades ago (2–6) and may be mechanistically linked to tumorigenesis (7).”
BackgroundThe DNA Methylome of Human Peripheral Blood Mononuclear Cells
Li, Y., Zhu, J., Tian, G., Li, N., Li, Q., Ye, M., Zheng, H., Yu, J., Wu, H., Sun, J., et al. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000533 · Cited by 318
“Loss of methylation in such transposable elements is known to be associated with tumorigenesis [15,16], and the above observations are consistent with DNA methylation playing a role in controlling retrotransposon mobility by lowering their activities and thereby”
ResultUHRF1 Overexpression Drives DNA Hypomethylation and Hepatocellular Carcinoma
Mudbhary, R., Hoshida, Y., Chernyavskaya, Y., Jacob, V., Villanueva, A., Fiel, M. I., Chen, X., Kojima, K., Thung, S., Bronson, R. T., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.01.003 · Cited by 309
“, 2013), our data combined with findings from others (Eden et al., 2003; Gaudet et al., 2003) suggest that DNA hypomethylation is a likely mechanism driving UHRF1mediated transformation.”
BackgroundResultEpigenetic and Chromatin Modifiers As Targeted Therapy of Hematologic Malignancies
Bhalla, K. N. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.16.600 · Cited by 308
Histone methyltransferases in cancer
Albert, M., & Helin, K. (2010) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2009.10.007 · Cited by 306
“Tumors re also induced in mice with genomic DNA hypomethylation [47], tressing the potential importance of histone and DNA methylaion marks for genome integrity.”
BackgroundEpigenetic mechanisms in tumorigenesis, tumor cell heterogeneity and drug resistance
Wilting, R. H., & Dannenberg, J.-H. (2012) · Drug Resistance Updates · doi:10.1016/j.drup.2012.01.008 · Cited by 303
“Mice xpressing reduced levels of Dnmt1 developed with high incience thymic lymphomas due to hypomethylation of pericentric eterochromatin, suggesting that reduced Dnmt1 levels may esult in chromosome missegregation and consequently genomic nstability (Gaudet et al., 2003).”
BackgroundDNA Methylation as a Therapeutic Target in Cancer
Issa, J.-P. J. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2076 · Cited by 301
“associated with chromosomal breaks (6) and to lead to an increased cancer incidence in specific animal models (7).”
BackgroundHur, K., Cejas, P., Feliu, J., Moreno-Rubio, J., Burgos, E., Boland, C. R., & Goel, A. (2014) · Gut · doi:10.1136/gutjnl-2012-304219 · Cited by 299
Epigenetic Changes in Prostate Cancer: Implication for Diagnosis and Treatment
Li, L.-C., Carroll, P. R., & Dahiya, R. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji010 · Cited by 299
Procainamide Is a Specific Inhibitor of DNA Methyltransferase 1
Lee, B. H., Yegnasubramanian, S., Lin, X., & Nelson, W. G. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505593200 · Cited by 295
Global DNA Methylation Level in Whole Blood as a Biomarker in Head and Neck Squamous Cell Carcinoma
Ting Hsiung, D., Marsit, C. J., Houseman, E. A., Eddy, K., Furniss, C. S., McClean, M. D., & Kelsey, K. T. (2007) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0636 · Cited by 297
“Furthermore, the causal role of hypomethylation in carcinogenesis has been established using mouse models with decreased methyltransferase activity (31).”
BackgroundYegnasubramanian, S., Haffner, M. C., Zhang, Y., Gurel, B., Cornish, T. C., Wu, Z., Irizarry, R. A., Morgan, J., Hicks, J., DeWeese, T. L., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6088 · Cited by 294
“Consistent with this hypothesis is the finding that mice with hypomorphic DNMT enzymes are prone to genetic instability and lymphomagenesis (49).”
BackgroundBurns, K. H., & Boeke, J. D. (2012) · Cell · doi:10.1016/j.cell.2012.04.019 · Cited by 293
“Further strengthening the connection between methylation and retroelements silencing, Dnmt1 knockout mice are not viable, and compound Dnmt1 heterozygotes, with one hypomorphic and one null allele, develop thymic lymphomas (Gaudet et al., 2003).”
Metadata
- Authors
- Gaudet, F., Hodgson, J. G., Eden, A., Jackson-Grusby, L., Dausman, J., Gray, J. W., Leonhardt, H., & Jaenisch, R.
- Affiliations
- Whitehead Institute for Biomedical Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02142, USA.
- University of California, San Francisco (US)
- Corresponding author
- Jaenisch, Rudolf
- Venue
- Science
- Published
- 2003-04-18
- Volume
- 300
- Issue
- 5618
- Pages
- 489-492
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1990381590
- Cited by
- 1,499
- References
- 34
- Citations by year
- 2026: 12 · 2025: 25 · 2024: 20 · 2023: 36 · 2022: 40 · 2021: 43 · 2020: 52 · 2019: 50 · 2018: 48 · 2017: 48 · 2016: 63 · 2015: 75 · 2014: 57 · 2013: 94 · 2012: 99
- FWCI
- 34.31
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (submittedVersion)
- Funders
- National Cancer Institute (R01CA087869, CA 87869)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Syndromes and Imprinting
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Keywords
- DNA hypomethylation, DNMT1, T-cell lymphoma, tumor induction, epigenetic silencing, chromosomal instability, mouse model
- MeSH terms
- DNA (Cytosine-5-)-Methyltransferase 1, Alleles, Animals, Birth Weight, Cell Transformation, Neoplastic, Chromosome Aberrations, DNA (Cytosine-5-)-Methyltransferases, Heterozygote, Mice, Transgenic, Moloney murine leukemia virus, Trisomy, Virus Activation, Gene Rearrangement, Gene Rearrangement, beta-Chain T-Cell Antigen Receptor, Gene Expression, Gene Expression Regulation, Neoplastic, Genes, myc, Lymphoma, T-Cell, DNA Methylation, Loss of Heterozygosity, Endogenous Retroviruses, Chromosomes, Mammalian, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.